Trinity Biotech plc TRIB
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$7.51$7.96
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Revenue | 11.07M | 10.83M | 15.86M | 15.15M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 11.07M | 10.83M | 15.86M | 15.15M | |
| Cost of Revenue | 7.17M | 6.22M | 10.98M | 9.84M | |
| Gross Profit | 3.90M | 4.61M | 4.88M | 5.31M | |
| SG&A Expenses | 5.79M | 6.98M | 8.37M | 6.52M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -1.84M | -- | 1.83M | -- | |
| Total Operating Expenses | 12.18M | 13.83M | 22.63M | 17.37M | |
| Operating Income | -1.11M | -3.00M | -6.78M | -2.22M | |
| Income Before Tax | -17.65M | -5.67M | -15.80M | -4.79M | |
| Income Tax Expenses | -174.00K | 294.00K | 585.00K | -35.00K | |
| Earnings from Continuing Operations | -17.48M | -5.97M | -16.38M | -4.76M | |
| Earnings from Discontinued Operations | -- | -- | -573.00K | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -17.48M | -5.97M | -16.96M | -4.76M | |
| EBIT | -1.11M | -3.00M | -6.78M | -2.22M | |
| EBITDA | -779.30K | -2.35M | -6.35M | -1.62M | |
| EPS Basic | -16.81K | -5.76K | -23.02K | -9.16 | |
| Normalized Basic EPS | -3.90 | -5.16 | -15.64 | -- | |
| EPS Diluted | -17.91K | -7.20K | -23.04K | -9.16 | |
| Normalized Diluted EPS | -3.90 | -5.16 | -15.64 | -- | |
| Average Basic Shares Outstanding | 623.70K | 621.10K | 442.00K | 10.39M | |
| Average Diluted Shares Outstanding | 1.00K | 1.00K | 700.00 | 519.30K | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |